57 research outputs found
Production of Gluten-free Bread Based on Rational Use of Natural Resources
The paper provides a scientific foundation for an integrated approach to the problem of expanding the range of bread for special purposes, including that for patients with celiac disease. The high cost of gluten-free foreign products makes rational use of cornflour and bread production technology based on it currently relevant. The use of enzymatic modification of cornflour starch is found to increase the gas formation of dough, which increases the accumulation of mono- and disaccharides up to 5.5 %. The use of surfactants to increase the gas retention capacity of dough is proved to be expedient. The effect of deoiled soy lecithin on the properties of dough and qualitative characteristics of cornbread was discovered. Dry egg albumen was added to make the bread structure porous. Preliminary hydration of protein was revealed to improve the leavening of bread. It was proved that semi-finished product, hydrolysate, in an amount of 50 % of the cornflour weight, 1 % soybean deoiled lecithin, 2.5 % vegetable oil, and 4 % dried egg albumen increase the gas retention capacity of dough and reduce its viscosity and gelatinization temperature to produce high-quality gluten-free corn pan bread
ΠΠ²Π°Π½ΡΠΎΠ²ΡΠ΅ ΡΠΎΡΠΊΠΈ: ΠΎΠΏΡΡ ΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠΈΡΡΠ΅ΠΌΠ°Ρ
The article is of a review nature, in which the dynamics of publication activity is analyzed and the possibilities of using quantum dots to solve various analytical problems are evaluated. The attention is paid to both traditional and relatively rare areas of analytical application of these nanostructures. A brief review of the types, advantages and disadvantages of synthesis methods, the influence of external factors on the band gap and luminescence intensity of inorganic nanosized phosphors, quantum dots of different nature, is presented. The areas of application and the main tasks solved with the use of quantum dots are systematized. Their analytical characteristics, operational properties and ways of regulating them are discussed. An effective way to control the analytical properties of the systems based on quantum dots is a directional change of the affinity for components by varying the nature of the stabilizing or modifying shell. Semiconductor colloidal quantum dots coated with a larger bandgap shell were selected for analytical use as the most commonly used systems due to their good photostability and fluorescence quantum yield. The advantages and disadvantages of other types of shells, as well as ways of modifying them, are shown. Solutions for organic analysis and medical diagnostics are considered. Systems of quantum dots used as biosensors with various guiding agents are considered, and their properties, advantages and disadvantages compared. Little studied issues and solutions in the direction of using quantum dots for developing sensor systems and their use for non-invasive analysis of living systems based on the results of detection of volatile organic compounds are identified.Keywords: quantum dots, application, analysis, reviewΠ‘ΡΠ°ΡΡΡ Π½ΠΎΡΠΈΡ ΠΎΠ±Π·ΠΎΡΠ½ΡΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ, Π² Π½Π΅ΠΉ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΡΠ΅ΡΡΡ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ° ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, ΠΎΡΠ΅Π½ΠΈΠ²Π°ΡΡΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ Π΄Π»Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π΄Π°Ρ. ΠΡΠΈ ΡΡΠΎΠΌ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΡΠ΄Π΅Π»ΡΠ΅ΡΡΡ ΠΊΠ°ΠΊ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΡΠΌ, ΡΠ°ΠΊ ΠΈ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ΅Π΄ΠΊΠΈΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡΠΌ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠΈΡ
Π½Π°Π½ΠΎΡΡΡΡΠΊΡΡΡ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΠΊΡΠ°ΡΠΊΠΈΠΉ ΠΎΠ±Π·ΠΎΡ ΡΠΈΠΏΠΎΠ², Π΄ΠΎΡΡΠΎΠΈΠ½ΡΡΠ² ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΎΠ² ΡΠΏΠΎΡΠΎΠ±ΠΎΠ² ΡΠΈΠ½ΡΠ΅Π·Π°, Π²Π»ΠΈΡΠ½ΠΈΡ Π²Π½Π΅ΡΠ½ΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π½Π° ΡΠΈΡΠΈΠ½Ρ Π·Π°ΠΏΡΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Π·ΠΎΠ½Ρ ΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ Π»ΡΠΌΠΈΠ½Π΅ΡΡΠ΅Π½ΡΠΈΠΈ Π½Π΅ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π°Π½ΠΎΡΠ°Π·ΠΌΠ΅ΡΠ½ΡΡ
Π»ΡΠΌΠΈΠ½ΠΎΡΠΎΡΠΎΠ² - ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ ΡΠ°Π·Π½ΠΎΠΉ ΠΏΡΠΈΡΠΎΠ΄Ρ. Π‘ΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΎΠ±Π»Π°ΡΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ Π·Π°Π΄Π°ΡΠΈ, ΡΠ΅ΡΠ°Π΅ΠΌΡΠ΅ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ. ΠΠ±ΡΡΠΆΠ΄Π°ΡΡΡΡ ΠΈΡ
Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ, ΡΠΊΡΠΏΠ»ΡΠ°ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΠΈ ΡΠΏΠΎΡΠΎΠ±Ρ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΈΠΌΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ ΡΠΏΠΎΡΠΎΠ±ΠΎΠΌ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ²ΠΎΠΉΡΡΠ²Π°ΠΌΠΈ ΡΠΈΡΡΠ΅ΠΌ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ ΡΠ²Π»ΡΠ΅ΡΡΡ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΡΠΎΠ΄ΡΡΠ²Π° ΠΊ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ°ΠΌ Π·Π° ΡΡΠ΅Ρ Π²Π°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΈΡΠΎΠ΄Ρ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·ΠΈΡΡΡΡΠ΅ΠΉ ΠΈΠ»ΠΈ ΠΌΠΎΠ΄ΠΈΡΠΈΡΠΈΡΡΡΡΠ΅ΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠΈ. ΠΠ»Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π² Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π»ΡΡ
Π²ΡΠ΄Π΅Π»Π΅Π½Ρ ΠΏΠΎΠ»ΡΠΏΡΠΎΠ²ΠΎΠ΄Π½ΠΈΠΊΠΎΠ²ΡΠ΅ ΠΊΠΎΠ»Π»ΠΎΠΈΠ΄Π½ΡΠ΅ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΠ΅ ΡΠΎΡΠΊΠΈ, ΠΏΠΎΠΊΡΡΡΡΠ΅ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠΎΠΉ Ρ Π±ΠΎΠ»ΡΡΠ΅ΠΉ ΡΠΈΡΠΈΠ½ΠΎΠΉ Π·Π°ΠΏΡΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Π·ΠΎΠ½Ρ, ΠΊΠ°ΠΊ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ ΡΠΈΡΡΠ΅ΠΌΡ, Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ ΠΈΡ
Ρ
ΠΎΡΠΎΡΠΈΠΌ ΡΠΎΡΠΎΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΠΈ ΠΈ ΠΊΠ²Π°Π½ΡΠΎΠ²ΠΎΠΌΡ Π²ΡΡ
ΠΎΠ΄Ρ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠΈΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ Π΄ΡΡΠ³ΠΈΡ
ΡΠΈΠΏΠΎΠ² ΠΎΠ±ΠΎΠ»ΠΎΡΠ΅ΠΊ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΏΠΎΡΠΎΠ±Ρ ΠΈΡ
ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π΄Π»Ρ ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΡΠΈΡΡΠ΅ΠΌΡ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ, ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΡΠ΅ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π±ΠΈΠΎΡΠ΅Π½ΡΠΎΡΠΎΠ², Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ Π½Π°ΠΏΡΠ°Π²Π»ΡΡΡΠΈΠΌΠΈ Π°Π³Π΅Π½ΡΠ°ΠΌΠΈ, ΡΠΎΠΏΠΎΡΡΠ°Π²Π»Π΅Π½Ρ ΠΈΡ
ΡΠ²ΠΎΠΉΡΡΠ²Π°, Π΄ΠΎΡΡΠΎΠΈΠ½ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΌΠ°Π»ΠΎ ΠΏΡΠΎΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠ΅ Π²ΠΎΠΏΡΠΎΡΡ ΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π² Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ Π΄Π»Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΡΠ΅Π½ΡΠΎΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΈΡ
Π΄Π»Ρ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΆΠΈΠ²ΡΡ
ΡΠΈΡΡΠ΅ΠΌ ΠΏΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π»Π΅Π³ΠΊΠΎ Π»Π΅ΡΡΡΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ.ΠΠ»ΡΡΠ΅Π²ΡΠ΅ ΡΠ»ΠΎΠ²Π°: ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΠ΅ ΡΠΎΡΠΊΠΈ, ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅, Π°Π½Π°Π»ΠΈΠ·, ΠΎΠ±Π·ΠΎ
Quantum dots: experience and prospects of application in analytical systems
Π‘ΡΠ°ΡΡΡ Π½ΠΎΡΠΈΡ ΠΎΠ±Π·ΠΎΡΠ½ΡΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ, Π² Π½Π΅ΠΉ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΡΠ΅ΡΡΡ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ° ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, ΠΎΡΠ΅Π½ΠΈΠ²Π°ΡΡΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ Π΄Π»Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π΄Π°Ρ. ΠΡΠΈ ΡΡΠΎΠΌ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΡΠ΄Π΅Π»ΡΠ΅ΡΡΡ ΠΊΠ°ΠΊ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΡΠΌ, ΡΠ°ΠΊ ΠΈ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ΅Π΄ΠΊΠΈΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡΠΌ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠΈΡ
Π½Π°Π½ΠΎΡΡΡΡΠΊΡΡΡ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΠΊΡΠ°ΡΠΊΠΈΠΉ ΠΎΠ±Π·ΠΎΡ ΡΠΈΠΏΠΎΠ², Π΄ΠΎΡΡΠΎΠΈΠ½ΡΡΠ² ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΎΠ² ΡΠΏΠΎΡΠΎΠ±ΠΎΠ² ΡΠΈΠ½ΡΠ΅Π·Π°, Π²Π»ΠΈΡΠ½ΠΈΡ Π²Π½Π΅ΡΠ½ΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π½Π° ΡΠΈΡΠΈΠ½Ρ Π·Π°ΠΏΡΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Π·ΠΎΠ½Ρ ΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ Π»ΡΠΌΠΈΠ½Π΅ΡΡΠ΅Π½ΡΠΈΠΈ Π½Π΅ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π°Π½ΠΎΡΠ°Π·ΠΌΠ΅ΡΠ½ΡΡ
Π»ΡΠΌΠΈΠ½ΠΎΡΠΎΡΠΎΠ² - ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ ΡΠ°Π·Π½ΠΎΠΉ ΠΏΡΠΈΡΠΎΠ΄Ρ. Π‘ΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΎΠ±Π»Π°ΡΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ Π·Π°Π΄Π°ΡΠΈ, ΡΠ΅ΡΠ°Π΅ΠΌΡΠ΅ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ. ΠΠ±ΡΡΠΆΠ΄Π°ΡΡΡΡ ΠΈΡ
Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ, ΡΠΊΡΠΏΠ»ΡΠ°ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΠΈ ΡΠΏΠΎΡΠΎΠ±Ρ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΈΠΌΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ ΡΠΏΠΎΡΠΎΠ±ΠΎΠΌ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ²ΠΎΠΉΡΡΠ²Π°ΠΌΠΈ ΡΠΈΡΡΠ΅ΠΌ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ ΡΠ²Π»ΡΠ΅ΡΡΡ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΡΠΎΠ΄ΡΡΠ²Π° ΠΊ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ°ΠΌ Π·Π° ΡΡΠ΅Ρ Π²Π°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΈΡΠΎΠ΄Ρ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·ΠΈΡΡΡΡΠ΅ΠΉ ΠΈΠ»ΠΈ ΠΌΠΎΠ΄ΠΈΡΠΈΡΠΈΡΡΡΡΠ΅ΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠΈ. ΠΠ»Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π² Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π»ΡΡ
Π²ΡΠ΄Π΅Π»Π΅Π½Ρ ΠΏΠΎΠ»ΡΠΏΡΠΎΠ²ΠΎΠ΄Π½ΠΈΠΊΠΎΠ²ΡΠ΅ ΠΊΠΎΠ»Π»ΠΎΠΈΠ΄Π½ΡΠ΅ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΠ΅ ΡΠΎΡΠΊΠΈ, ΠΏΠΎΠΊΡΡΡΡΠ΅ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠΎΠΉ Ρ Π±ΠΎΠ»ΡΡΠ΅ΠΉ ΡΠΈΡΠΈΠ½ΠΎΠΉ Π·Π°ΠΏΡΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Π·ΠΎΠ½Ρ, ΠΊΠ°ΠΊ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ ΡΠΈΡΡΠ΅ΠΌΡ, Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ ΠΈΡ
Ρ
ΠΎΡΠΎΡΠΈΠΌ ΡΠΎΡΠΎΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΠΈ ΠΈ ΠΊΠ²Π°Π½ΡΠΎΠ²ΠΎΠΌΡ Π²ΡΡ
ΠΎΠ΄Ρ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠΈΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ Π΄ΡΡΠ³ΠΈΡ
ΡΠΈΠΏΠΎΠ² ΠΎΠ±ΠΎΠ»ΠΎΡΠ΅ΠΊ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΏΠΎΡΠΎΠ±Ρ ΠΈΡ
ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π΄Π»Ρ ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΡΠΈΡΡΠ΅ΠΌΡ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ, ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΡΠ΅ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π±ΠΈΠΎΡΠ΅Π½ΡΠΎΡΠΎΠ², Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ Π½Π°ΠΏΡΠ°Π²Π»ΡΡΡΠΈΠΌΠΈ Π°Π³Π΅Π½ΡΠ°ΠΌΠΈ, ΡΠΎΠΏΠΎΡΡΠ°Π²Π»Π΅Π½Ρ ΠΈΡ
ΡΠ²ΠΎΠΉΡΡΠ²Π°, Π΄ΠΎΡΡΠΎΠΈΠ½ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΌΠ°Π»ΠΎ ΠΏΡΠΎΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠ΅ Π²ΠΎΠΏΡΠΎΡΡ ΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π² Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΊΠ²Π°Π½ΡΠΎΠ²ΡΡ
ΡΠΎΡΠ΅ΠΊ Π΄Π»Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΡΠ΅Π½ΡΠΎΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΈΡ
Π΄Π»Ρ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΆΠΈΠ²ΡΡ
ΡΠΈΡΡΠ΅ΠΌ ΠΏΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π»Π΅Π³ΠΊΠΎ Π»Π΅ΡΡΡΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ.The article is of a review nature, in which the dynamics of publication activity is analyzed and the possibilities of using quantum dots to solve various analytical problems are evaluated. The attention is paid to both traditional and relatively rare areas of analytical application of these nanostructures. A brief review of the types, advantages and disadvantages of synthesis methods, the influence of external factors on the band gap and luminescence intensity of inorganic nanosized phosphors, quantum dots of different nature, is presented. The areas of application and the main tasks solved with the use of quantum dots are systematized. Their analytical characteristics, operational properties and ways of regulating them are discussed. An effective way to control the analytical properties of the systems based on quantum dots is a directional change of the affinity for components by varying the nature of the stabilizing or modifying shell. Semiconductor colloidal quantum dots coated with a larger bandgap shell were selected for analytical use as the most commonly used systems due to their good photostability and fluorescence quantum yield. The advantages and disadvantages of other types of shells, as well as ways of modifying them, are shown. Solutions for organic analysis and medical diagnostics are considered. Systems of quantum dots used as biosensors with various guiding agents are considered, and their properties, advantages and disadvantages compared. Little studied issues and solutions in the direction of using quantum dots for developing sensor systems and their use for non-invasive analysis of living systems based on the results of detection of volatile organic compounds are identified.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΎ Π·Π° ΡΡΠ΅Ρ Π³ΡΠ°Π½ΡΠ° Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠ³ΠΎ Π½Π°ΡΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π° β 23-23-00609, https://rscf.ru/project/ 23-23-00609.This work was supported by the Russian Science Foundation (grant no. β 23-23-00609, https://rscf.ru/project/ 23-23-00609
CLINICALLY RELEVANT MINOR HISTOCOMPATIBILITY ANTIGENS FOR RUSSIAN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Hematopoietic stem cell transplantation (HSCT) from healthy donors is used for blood cancer treatment. Alloreactive graft-versus-host disease (GvHD) is one of the post-transplant detrimental side effects, and the main reason for GVHD after HSCT fully matched for human leukocyte peptide antigens (HLA) presented by HLA molecules on cell surface. These polymorphic peptides, minor histocompatibility antigens (MiHA), arise from any genes, including those expressed at hematopoietic tissues. The latter may lead to the s.c. graft-versus-leukemia effect (GvL), thus preventing relapse of a malignancy. A*02:01 is one of the most frequent HLA alleles for European part of Russia. We assessed frequencies for 20 MiHA-encoded genetic polymorphisms, presented via A*02:01 allele, for plausible bone marrow donors, or hematopoietic stem cells (HSC) from the Donor Registry at Russian National Research Center for Hematology, we have also determined a number of immunogenic mismatches for these 20 MiHA in real donor β recipient pairs. A total of 608 potential donors, 90 donors and 92 recipients were genotyped. Using public data, we have shown that frequencies for MiHA coding genes are most close to appropriate frequencies among the European population. We have calculated probability of MiHA-specific alloimmune response after HSCT: there are chances of 33 and 75% for three or more immunogenic mismatches (IM) for related and unrelated HSCTs, respectively. Real frequencies for immune mismatch in 20 related and 20 unrelated donor β recipient pairs are in accordance with estimated theoretical probabilities. As based on the calculated frequencies, we suggest the LB-NDC80- 1P/A, LB-CCL4- 1T, and HA-1 MiHA to be the most promising minor antigens for targeted cell therapies of hematopoietic tissue malignancies. The data obtained could be used for planning allo-HSCTs in Russian patients
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer
The phenomenon of high sugar consumption by tumor cells is known as Warburg effect. It results from a high glycolysis rate, used by tumors as preferred metabolic pathway even in aerobic conditions. Targeting the Warburg effect to specifically deliver sugar conjugated cytotoxic compounds into tumor cells is a promising approach to create new selective drugs. We designed, synthesized, and analyzed a library of novel 6-S-(1,4-naphthoquinone-2-yl)-d-glucose chimera molecules (SABs)—novel sugar conjugates of 1,4-naphthoquinone analogs of the sea urchin pigments spinochromes, which have previously shown anticancer properties. A sulfur linker (thioether bond) was used to prevent potential hydrolysis by human glycoside-unspecific enzymes. The synthesized compounds exhibited a Warburg effect mediated selectivity to human prostate cancer cells (including highly drug-resistant cell lines). Mitochondria were identified as a primary cellular target of SABs. The mechanism of action included mitochondria membrane permeabilization, followed by ROS upregulation and release of cytotoxic mitochondrial proteins (AIF and cytochrome C) to the cytoplasm, which led to the consequent caspase-9 and -3 activation, PARP cleavage, and apoptosis-like cell death. These results enable us to further clinically develop these compounds for effective Warburg effect targeting
ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ Π‘ΠΠ£Π§ΠΠ Π£Π‘ΠΠΠ¨ΠΠΠΠ ΠΠΠ§ΠΠΠΠ― ΠΠΠΠ¬ΠΠΠΠ Π ΠΠΠΠ ΠΠΠ©ΠΠΠΠΠ IV Π‘Π’ΠΠΠΠ
Background. Esophageal cancer is among the ten most common cancers and causes-related mortality worldwide. Most patients present with an advanced stage tumor at diagnosis. To treat patients with esophagealΒ cancer, radiation therapy in combination with chemotherapy is usually used. In the clinic of A.F. Tsyb Medical Radiological Scientific Center, patients with advanced esophageal cancer are treated with split-course radiotherapy delivered in two fractions (1β1.5 Gy) with a 4-hour interval. The positive effect is observed significantly earlier than in conventional radiotherapy.Case description. A 50-year-old male patient presented with complaints of hoarseness of voice and difficulty swallowing in February 2015. The patient was diagnosed with stage cΠ’4N2M1 cervical esophageal cancer (tumor length 3.5 cm) with metastases in cervical lymph nodes and the thyroid and esophageal stenosis (stage IV). Cytological examination revealed keratinizing squamous cell esophageal carcinoma. The tumor was considered inoperable. The patient underwent gastrostomy. Radiation therapy delivered to the tumor and metastases was performed 5 times a week using two lateral fields and one anterior field. The total radiation dose was 60 Gy. A complete response was achieved. Three courses of chemotherapy with carboplatin (AUC 6), paclitaxel (75 mg/m2 ) with a 21-day interval were administered 2 months after radiotherapy. In January 2016, new metastases in the thyroid were detected. Thyroidectomy with microsurgical neurolysis of the laryngeal nerves was performed. The patient is alive 3 years and 7 months after diagnosis.Conclusion. The use of nonconventional fractionated radiotherapy schedules in combination with chemotherapy allows satisfactory treatment outcomes in patients with advanced esophageal cancer to be obtained.Β ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π Π°ΠΊ ΠΏΠΈΡΠ΅Π²ΠΎΠ΄Π° (Π Π) Π½Π°Ρ
ΠΎΠ΄ΠΈΡΡΡ Π² ΠΏΠ΅ΡΠ²ΠΎΠΉ Π΄Π΅ΡΡΡΠΊΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Ρ Π²ΡΡΠΎΠΊΠΎΠΉ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΡΡ. Π Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΡΠ»ΡΡΠ°Π΅Π² Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΏΠΎΡΡΠ°Π½ΠΎΠ²ΠΊΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° ΡΠΆΠ΅ ΠΈΠΌΠ΅Π΅ΡΡΡ IIIβIV ΡΡΠ°Π΄ΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°. ΠΠ΅ΡΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠΌ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠΌ β ΡΡΠ΅Π·Π²ΡΡΠ°ΠΉΠ½ΠΎ ΡΠ»ΠΎΠΆΠ½Π°Ρ Π·Π°Π΄Π°ΡΠ°, Π΄Π»Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΊΠΎΡΠΎΡΠΎΠΉ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΡΡΡ Π»ΡΡΠ΅Π²Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ Π² ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠΈ Ρ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠ΅ΠΉ. Π ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ΅ ΠΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠ³ΠΎ ΡΠ°Π΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π½Π°ΡΡΠ½ΠΎΠ³ΠΎ Π¦Π΅Π½ΡΡΠ° ΠΈΠΌ. Π.Π€. Π¦ΡΠ±Π° ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌ ΡΠ°ΠΊΠΎΠΌ ΠΏΠΈΡΠ΅Π²ΠΎΠ΄Π° ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° Π΄ΡΠΎΠ±Π»Π΅Π½ΠΈΡ ΡΠΊΡΡΠΏΠ½Π΅Π½Π½ΠΎΠΉ Π΄Π½Π΅Π²Π½ΠΎΠΉ Π΄ΠΎΠ·Ρ (2,5 ΠΡ) Π½Π° 2 ΡΡΠ°ΠΊΡΠΈΠΈ (1β1,5 ΠΡ) Ρ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π»ΠΎΠΌ ΠΌΠ΅ΠΆΠ΄Ρ ΡΡΠ°ΠΊΡΠΈΡΠΌΠΈ 4 Ρ. ΠΠΎΠ»ΡΠ½ΡΠ΅ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π»Π΅Π³ΡΠ΅ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΡΡ Π»Π΅ΡΠ΅Π½ΠΈΠ΅, Π° ΡΡΡΠ΅ΠΊΡ ΡΠ΅ΠΊΠ°Π½Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠΈΡΠ΅Π²ΠΎΠ΄Π° ΠΈ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»ΠΈ ΠΏΡΠΈ ΠΏΡΠΎΠ³Π»Π°ΡΡΠ²Π°Π½ΠΈΠΈ ΠΏΠΈΡΠΈ Π½Π°ΡΡΡΠΏΠ°ΡΡ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ°Π½ΡΡΠ΅, ΡΠ΅ΠΌ ΠΏΡΠΈ ΠΊΠΎΠ½Π²Π΅Π½ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΌ ΠΎΠ±Π»ΡΡΠ΅Π½ΠΈΠΈ.ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ. ΠΠΎΠ»ΡΠ½ΠΎΠΉ ΠΎΠ±ΡΠ°ΡΠΈΠ»ΡΡ Π² ΠΠ ΠΠ¦ ΠΈΠΌ. Π.Π€. Π¦ΡΠ±Π° Π² ΡΠ΅Π²ΡΠ°Π»Π΅ 2015 Π³. Ρ ΠΆΠ°Π»ΠΎΠ±Π°ΠΌΠΈ Π½Π° ΠΎΡΠΈΠΏΠ»ΠΎΡΡΡ Π³ΠΎΠ»ΠΎΡΠ° ΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΎΡ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΠΏΠΈΡΠΈ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ Π΄ΠΈΠ°Π³Π½ΠΎΠ· ΡΠ°ΠΊ ΡΠ΅ΠΉΠ½ΠΎΠ³ΠΎ ΠΎΡΠ΄Π΅Π»Π° ΠΏΠΈΡΠ΅Π²ΠΎΠ΄Π° Ρ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Π°ΠΌΠΈ Π² Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ·Π»Ρ ΡΠ΅ΠΈ ΠΈ Π² ΡΠΈΡΠΎΠ²ΠΈΠ΄Π½ΡΡ ΠΆΠ΅Π»Π΅Π·Ρ ΡΠ’4N2M1, ΡΡΠ΅Π½ΠΎΠ· ΠΏΠΈΡΠ΅Π²ΠΎΠ΄Π° IV ΡΡΠ΅ΠΏΠ΅Π½ΠΈ, ΠΏΡΠΎΡΡΠΆΠ΅Π½Π½ΠΎΡΡΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ 7,5 ΡΠΌ. ΠΠΏΡΡ
ΠΎΠ»Ρ ΠΏΡΠΈΠ·Π½Π°Π½Π° Π½Π΅ΠΎΠΏΠ΅ΡΠ°Π±Π΅Π»ΡΠ½ΠΎΠΉ, Π±ΠΎΠ»ΡΠ½ΠΎΠΌΡ Π±ΡΠ»ΠΎ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½ΠΎ Π»ΡΡΠ΅Π²ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Ρ ΠΏΠ°Π»Π»ΠΈΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π»ΡΡ, Π²ΡΠΏΠΎΠ»Π½Π΅Π½Π° Π³Π°ΡΡΡΠΎΡΡΠΎΠΌΠΈΡ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π° Π»ΡΡΠ΅Π²Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ² Π² ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΠ΅ΠΆΠΈΠΌΠ΅ Ρ 3 ΠΏΠΎΠ»Π΅ΠΉ: Ρ Π΄Π²ΡΡ
Π±ΠΎΠΊΠΎΠ²ΡΡ
ΡΠ°Π·ΠΌΠ΅ΡΠΎΠΌ 6Γ11 ΡΠΌ ΠΈ ΠΏΠ΅ΡΠ΅Π΄Π½Π΅Π³ΠΎ ΠΏΠΎΠ»Ρ 12Γ11 ΡΠΌ 5 ΡΠ°Π· Π² Π½Π΅Π΄Π΅Π»Ρ Ρ Π΄ΡΠΎΠ±Π»Π΅Π½ΠΈΠ΅ΠΌ Π΄Π½Π΅Π²Π½ΠΎΠΉ Π΄ΠΎΠ·Ρ. Π‘ΡΠΌΠΌΠ°ΡΠ½Π°Ρ ΠΎΡΠ°Π³ΠΎΠ²Π°Ρ Π΄ΠΎΠ·Π° ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 60 ΠΡ. ΠΠΎΠ»ΡΡΠ΅Π½ ΠΏΠΎΠ»Π½ΡΠΉ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΡΡΡΠ΅ΠΊΡ Π»Π΅ΡΠ΅Π½ΠΈΡ. Π§Π΅ΡΠ΅Π· 2 ΠΌΠ΅Ρ Π±ΠΎΠ»ΡΠ½ΠΎΠΌΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Ρ 3 ΠΊΡΡΡΠ° Π΄Π²ΡΡ
ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ½ΠΎΠΉ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π ΡΠ½Π²Π°ΡΠ΅ 2016 Π³. Π²ΡΠΏΠΎΠ»Π½Π΅Π½Π° ΡΠΈΡΠ΅ΠΎΠΈΠ΄ΡΠΊΡΠΎΠΌΠΈΡ Ρ ΠΌΠΈΠΊΡΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π½Π΅Π²ΡΠΎΠ»ΠΈΠ·ΠΎΠΌ Π³ΠΎΡΡΠ°Π½Π½ΡΡ
Π½Π΅ΡΠ²ΠΎΠ². ΠΠΎΠ»ΡΠ½ΠΎΠΉ Π½Π°Ρ
ΠΎΠ΄ΠΈΡΡΡ ΠΏΠΎΠ΄ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ΠΌ 3 Π³ΠΎΠ΄Π° 7 ΠΌΠ΅Ρ ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΠΆΠ°Π»ΠΎΠ± Π½Π΅ ΠΏΡΠ΅Π΄ΡΡΠ²Π»ΡΠ΅Ρ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π½Π΅ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΡΡ
ΡΠ΅ΠΆΠΈΠΌΠΎΠ² ΡΡΠ°ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π»ΡΡΠ΅Π²ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π² ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠΈ Ρ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠ΅ΠΉ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΏΠΎΠ»ΡΡΠΈΡΡ ΡΠ΄ΠΎΠ²Π»Π΅ΡΠ²ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌ ΡΠ°ΠΊΠΎΠΌ ΠΏΠΈΡΠ΅Π²ΠΎΠ΄Π°.
A CASE REPORT OF SUCCESSFUL TREATMENT OF STAGE IV ESOPHAGEAL CANCER
Background. Esophageal cancer is among the ten most common cancers and causes-related mortality worldwide. Most patients present with an advanced stage tumor at diagnosis. To treat patients with esophagealΒ cancer, radiation therapy in combination with chemotherapy is usually used. In the clinic of A.F. Tsyb Medical Radiological Scientific Center, patients with advanced esophageal cancer are treated with split-course radiotherapy delivered in two fractions (1β1.5 Gy) with a 4-hour interval. The positive effect is observed significantly earlier than in conventional radiotherapy.Case description. A 50-year-old male patient presented with complaints of hoarseness of voice and difficulty swallowing in February 2015. The patient was diagnosed with stage cΠ’4N2M1 cervical esophageal cancer (tumor length 3.5 cm) with metastases in cervical lymph nodes and the thyroid and esophageal stenosis (stage IV). Cytological examination revealed keratinizing squamous cell esophageal carcinoma. The tumor was considered inoperable. The patient underwent gastrostomy. Radiation therapy delivered to the tumor and metastases was performed 5 times a week using two lateral fields and one anterior field. The total radiation dose was 60 Gy. A complete response was achieved. Three courses of chemotherapy with carboplatin (AUC 6), paclitaxel (75 mg/m2 ) with a 21-day interval were administered 2 months after radiotherapy. In January 2016, new metastases in the thyroid were detected. Thyroidectomy with microsurgical neurolysis of the laryngeal nerves was performed. The patient is alive 3 years and 7 months after diagnosis.Conclusion. The use of nonconventional fractionated radiotherapy schedules in combination with chemotherapy allows satisfactory treatment outcomes in patients with advanced esophageal cancer to be obtained
- β¦